A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity
Clinical trial NCT05712876 · COMPLETED
Trial details
- NCT number
- NCT05712876
- Sponsor
- Cytoki Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-26
- Primary completion
- 2024-01-04
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.